Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mason Marks

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Neuropharmacology|December 24, 2022
The varieties of psychedelic lawMason Marks
JAMA|December 8, 2023
State-Regulated Psychedelics on a Collision Course With FDAMason Marks
JAMA|July 30, 2024
Psychedelic Therapy Scrutinized by FDA Advisory Committee?Mason Marks
JAMA|December 21, 2021
Legalization of Psychedelic SubstancesMason Marks
Nature Medicine|January 28, 2023
Drug scheduling limits access to essential medicines and should be reformedMason Marks, Carmel Shachar
JAMA|October 16, 2024
FTC Regulation of AI-Generated Medical DisinformationClaudia E Haupt, Mason Marks
The New England Journal of Medicine|November 6, 2023
How Should the FDA Evaluate Psychedelic Medicine?Mason Marks, I Glenn Cohen
JAMA|July 6, 2023
AI Chatbots, Health Privacy, and Challenges to HIPAA ComplianceMason Marks, Claudia E Haupt
JAMA|March 27, 2023
AI-Generated Medical Advice-GPT and BeyondClaudia E Haupt, Mason Marks
Nature Medicine|October 5, 2021
Psychedelic therapy: a roadmap for wider acceptance and utilizationMason Marks, I Glenn Cohen
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Neuropharmacology|December 24, 2022
The varieties of psychedelic lawMason Marks
JAMA|December 8, 2023
State-Regulated Psychedelics on a Collision Course With FDAMason Marks
JAMA|July 30, 2024
Psychedelic Therapy Scrutinized by FDA Advisory Committee?Mason Marks
JAMA|December 21, 2021
Legalization of Psychedelic SubstancesMason Marks
Nature Medicine|January 28, 2023
Drug scheduling limits access to essential medicines and should be reformedMason Marks, Carmel Shachar
JAMA|October 16, 2024
FTC Regulation of AI-Generated Medical DisinformationClaudia E Haupt, Mason Marks
The New England Journal of Medicine|November 6, 2023
How Should the FDA Evaluate Psychedelic Medicine?Mason Marks, I Glenn Cohen
JAMA|July 6, 2023
AI Chatbots, Health Privacy, and Challenges to HIPAA ComplianceMason Marks, Claudia E Haupt
JAMA|March 27, 2023
AI-Generated Medical Advice-GPT and BeyondClaudia E Haupt, Mason Marks
Nature Medicine|October 5, 2021
Psychedelic therapy: a roadmap for wider acceptance and utilizationMason Marks, I Glenn Cohen
Pageof 2